Oracea (40mg doxycycline)

Oracea is a once per day 40mg (30mg immediate release and 10mg delayed release) doxycycline treatment for the papules and pustles of rosacea. Galderma promote Oracea as superior to 50mg a day of generic doxycycline because Oracea is a low enough dose to be promoted as an `anti-inflamatory only’ treatment and not suffering from potential problems of higher doses of antibiotics.

Be sure to checkout the Oracea User Reviews.

Recent Rosacea Blog Posts

In the news this week is an announcement that Oracea is on its way to being approved for sale in Germany, UK, Italy, Austria, Ireland, Sweden, Finland, Luxembourg and The Netherlands. European Regulatory Authority (EMEA) Recommends Granting Of Marketing Authorization For MediGene’s Drug Oracea MediGene AG announced that the European Medicines Agency (EMEA) Committee for […]

Continue Reading

Collagenex is set to become a subsidiary of the much bigger Galderma, after CollaGenex agreed to a merger. So 2 of the biggest pharmaceutical companies involved with make rosacea treatments are to become the same company. Galderma has long been associated with rosacea treatment, and is best known for the metronidazole based topicals metrogel, metrocream […]

Continue Reading

This paper comes up with the seemingly simple and innocuous result that rosacea sufferers are more likely to fill prescription repeats for oral treatments compared to topicals. This lead to the suggestion by Collagenex that sufferers are generally more satisfied with the effects of oral treatments. In recent press release they further suggested that this […]

Continue Reading

Collagenex is reporting today that Oracea is equally effective as 100mg of doxycycline. This latest press release is a culmination of a trial that we have reported previously – oracea plus metrogel, better than 100mg doxycycline plus metrogel ? and also a 2007 SkinMed paper; maximum effective dose of doxycycline is 40mg a day. The […]

Continue Reading

Thanks for the tip from Ben. A clinical trial listed for treating both facial and ocular rosacea with Oracea suggests that Oracea might soon be marketed directly as an ocular rosacea treatment. This phase 2 trial’s purpose is to determine the safety and efficacy of sub-antimicrobial dose doxycycline in the treatment of patients who have […]

Continue Reading

 

Top